Major determinants in hepatic disposition of polystyrene nanospheres: implication for rational design of particulate drug carriers
- PMID: 12661696
- DOI: 10.1615/critrevtherdrugcarriersyst.v19.i45.10
Major determinants in hepatic disposition of polystyrene nanospheres: implication for rational design of particulate drug carriers
Abstract
The clearance of colloidal particles from the blood circulation occurs by phagocytes and/or endothelial cells, mainly in the liver, the spleen, and the bone marrow. The relative distribution of the injected particles in these organs is known to depend on various factors such as the size and surface properties of the particles and the type of serum proteins adsorbed onto the surface of particles. The basic principles behind their distribution characteristics into the reticuloendothelial system, however, remain unclear. This article reviews major determinants in hepatic disposition of polystyrene nanospheres, especially the relationship among physicochemical properties of the particle surface, the type of blood components associated onto the surface of particles, and their in vivo disposition characteristics in rats, and considerations to be given and implication for the rational design of particulate drug carriers are discussed.
Similar articles
-
Important role of serum proteins associated on the surface of particles in their hepatic disposition.J Control Release. 2002 Sep 18;83(1):89-96. doi: 10.1016/s0168-3659(02)00196-7. J Control Release. 2002. PMID: 12220841
-
Mechanisms of hepatic disposition of polystyrene microspheres in rats: effects of serum depend on the sizes of microspheres.J Control Release. 1999 Sep 20;61(3):241-50. doi: 10.1016/s0168-3659(99)00121-2. J Control Release. 1999. PMID: 10477798
-
Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum.Biochim Biophys Acta. 1993 Nov 7;1179(2):157-65. doi: 10.1016/0167-4889(93)90137-e. Biochim Biophys Acta. 1993. PMID: 8218358
-
Shielding Therapeutic Drug Carriers from the Mononuclear Phagocyte System: A Review.Crit Rev Ther Drug Carrier Syst. 2016;33(6):489-567. doi: 10.1615/CritRevTherDrugCarrierSyst.2016012303. Crit Rev Ther Drug Carrier Syst. 2016. PMID: 27992308 Review.
-
Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow.Crit Rev Ther Drug Carrier Syst. 1990;7(3):187-209. Crit Rev Ther Drug Carrier Syst. 1990. PMID: 2073686 Review.
Cited by
-
Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.J Histochem Cytochem. 2011 Aug;59(8):727-40. doi: 10.1369/0022155411410885. J Histochem Cytochem. 2011. PMID: 21804077 Free PMC article.
-
Intravenous hydrophobic drug delivery: a porous particle formulation of paclitaxel (AI-850).Pharm Res. 2005 Mar;22(3):347-55. doi: 10.1007/s11095-004-1871-1. Pharm Res. 2005. PMID: 15835739